Endoscopic Treatment of Isolated Sphenoid Sinus Disease in Children

Peng-Peng Wang1, Wen-Tong Ge1, Xin Ni1

  • 11 Department of Otorhinolaryngology, Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, Xi Cheng District, Beijing, People's Republic of China.

Insights

Pediatric isolated sphenoid sinus disease (ISSD) presents with varied symptoms, often requiring endoscopic surgery. Ultra-low-dose CT and MRI aid diagnosis, with the endoscopic transostial approach effective for benign lesions.

Area of Science:

  • Otolaryngology
  • Pediatric Surgery
  • Radiology

Background:

  • Isolated sphenoid sinus disease (ISSD) in children presents with nonspecific symptoms, complicating diagnosis.
  • The spectrum of ISSD includes inflammatory conditions, mucoceles, and tumors, necessitating accurate diagnostic imaging and surgical planning.

Purpose of the Study:

  • To explore the disease spectrum, clinical characteristics, and diagnostic/endoscopic treatment approaches for ISSD in children.
  • To evaluate the efficacy and safety of the endoscopic transostial approach for pediatric ISSD.

Main Methods:

  • Retrospective review of 19 pediatric patients treated for ISSD between 2012 and 2016.
  • Utilized ultra-low-dose paranasal sinus computed tomography (CT) and magnetic resonance imaging (MRI) for diagnosis.
  • All patients underwent endoscopic transostial surgery for diagnosis and/or treatment.

Main Results:

  • Common symptoms included atypical headache, nasal congestion, and epistaxis, with headache in 42% of patients.
  • Inflammatory conditions were the most frequent pathologies, followed by benign tumors and mucoceles.
  • The endoscopic transostial approach was successfully performed in all patients without complications, effectively managing benign lesions.

Conclusions:

  • ISSD in children encompasses diverse pathologies, with inflammatory disease being most common.
  • Ultra-low-dose CT is recommended for evaluating sphenoid sinus disease, with MRI crucial for suspected tumors.
  • The endoscopic transostial approach is a suitable and safe method for managing pediatric ISSD, particularly benign lesions.

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
850
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
462
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
512
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias01:16

ECG Interpretation of Arrhythmias I: Sinus Arrhythmias

Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
799
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
524